Concepedia

Mei Mei Hu

MM

Statistics

Publications

3

Citations

84

H-Index

3

Active since

2022

Affiliations

CTI BioPharma (Italy)(Current)

Mei Mei Hu is an author at CTI BioPharma (Italy) specializing in vaccination, vaccine immunology, and immunization.

Publications per year

2022–2022

3

Publications

3

A novel RBD-protein/peptide vaccine elicits broadly neutralizing antibodies and protects mice and macaques against SARS-CoV-2

Shixia Wang, Chang Yi Wang, Hui-Kai Kuo et al. · Emerging Microbes & Infections · 2022 · 33 citations · Full text

, , +17

Immunogenicity and safety of an inactivated SARS-CoV-2 vaccine (Sinopharm BBIBP-CorV) coadministered with quadrivalent split-virion inactivated influenza vaccine and 23-valent pneumococcal polysaccharide vaccine in China: A multicentre, non-inferiority, open-label, randomised, controlled, phase 4 trial

Haiping Chen, Shaoying Chang, Mei Mei Hu et al. · Vaccine · 2022 · 26 citations · Full text

, , +17

High Neutralizing Antibody Levels Against Severe Acute Respiratory Syndrome Coronavirus 2 Omicron BA.1 and BA.2 After UB-612 Vaccine Booster

Farshad Guirakhoo, Shixia Wang, Chang Yi Wang et al. · The Journal of Infectious Diseases · 2022 · 25 citations · Full text

, , +17

1–3 of 3